Rapid peroxynitrite reduction by human peroxiredoxin 3: Implications for the fate of oxidants in mitochondria

2019 ◽  
Vol 130 ◽  
pp. 369-378 ◽  
Author(s):  
María Inés De Armas ◽  
Romina Esteves ◽  
Nicolás Viera ◽  
Aníbal M. Reyes ◽  
Mauricio Mastrogiovanni ◽  
...  
Keyword(s):  
Antioxidants ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 150
Author(s):  
Kimberly J. Nelson ◽  
Terri Messier ◽  
Stephanie Milczarek ◽  
Alexis Saaman ◽  
Stacie Beuschel ◽  
...  

A central hallmark of tumorigenesis is metabolic alterations that increase mitochondrial reactive oxygen species (mROS). In response, cancer cells upregulate their antioxidant capacity and redox-responsive signaling pathways. A promising chemotherapeutic approach is to increase ROS to levels incompatible with tumor cell survival. Mitochondrial peroxiredoxin 3 (PRX3) plays a significant role in detoxifying hydrogen peroxide (H2O2). PRX3 is a molecular target of thiostrepton (TS), a natural product and FDA-approved antibiotic. TS inactivates PRX3 by covalently adducting its two catalytic cysteine residues and crosslinking the homodimer. Using cellular models of malignant mesothelioma, we show here that PRX3 expression and mROS levels in cells correlate with sensitivity to TS and that TS reacts selectively with PRX3 relative to other PRX isoforms. Using recombinant PRXs 1–5, we demonstrate that TS preferentially reacts with a reduced thiolate in the PRX3 dimer at mitochondrial pH. We also show that partially oxidized PRX3 fully dissociates to dimers, while partially oxidized PRX1 and PRX2 remain largely decameric. The ability of TS to react with engineered dimers of PRX1 and PRX2 at mitochondrial pH, but inefficiently with wild-type decameric protein at cytoplasmic pH, supports a novel mechanism of action and explains the specificity of TS for PRX3. Thus, the unique structure and propensity of PRX3 to form dimers contribute to its increased sensitivity to TS-mediated inactivation, making PRX3 a promising target for prooxidant cancer therapy.


2014 ◽  
Vol 76 ◽  
pp. S136
Author(s):  
Alix Wozniak ◽  
Brian Cunniff ◽  
Kendra DeCosta ◽  
Patrick Sweeney ◽  
Nicholas Heintz

Biochemistry ◽  
2010 ◽  
Vol 49 (44) ◽  
pp. 9677-9677 ◽  
Author(s):  
Andrew G. Cox ◽  
Alexander V. Peskin ◽  
Louise N. Paton ◽  
Christine C. Winterbourn ◽  
Mark B. Hampton

Gene ◽  
2021 ◽  
Vol 771 ◽  
pp. 145350
Author(s):  
Anushka Vidurangi Samaraweera ◽  
M.D. Neranjan Tharuka ◽  
Thanthrige Thiunuwan Priyathilaka ◽  
Hyerim Yang ◽  
Sukkyoung Lee ◽  
...  

2010 ◽  
Vol 49 ◽  
pp. S77-S78
Author(s):  
liuji Chen ◽  
Ren Na ◽  
Yuhong Liu ◽  
Hanyu Liang ◽  
Holly Van Remmen ◽  
...  

Circulation ◽  
2006 ◽  
Vol 113 (14) ◽  
pp. 1779-1786 ◽  
Author(s):  
Shouji Matsushima ◽  
Tomomi Ide ◽  
Mayumi Yamato ◽  
Hidenori Matsusaka ◽  
Fumiyuki Hattori ◽  
...  

Endocrinology ◽  
2009 ◽  
Vol 150 (11) ◽  
pp. 5171-5180 ◽  
Author(s):  
Goele Aerts ◽  
Rafael Arrojo e Drigo ◽  
Stijn L. J. Van Herck ◽  
Eva Sammels ◽  
Delphine Mirebeau-Prunier ◽  
...  

The type 3 iodothyronine deiodinase (D3) is the primary deiodinase that inactivates thyroid hormone. Immunoprecipitation of D3, followed by fluorescent two-dimensional difference gel electrophoresis and mass spectrometry, identified peroxiredoxin 3 (Prx3) as a D3-associated protein. This interaction was confirmed using reverse coimmunoprecipitation, in which pull-down of Prx3 resulted in D3 isolation, and by fluorescence resonance energy transfer between cyan fluorescent protein-D3 and yellow fluorescent protein-Prx3. Prx3 overexpression did not change D3 activity in transfected HEK 293 cells; however, Prx3 knockdown resulted in a 50% decrease in D3-mediated whole-cell deiodination. Notably, D3 activity of cell lysates with dithiothreitol as an exogenous reducing factor and D3 protein levels were not decreased with Prx3 knockdown, indicating that the observed reduction in whole-cell deiodination was not simply due to a decrease in D3 enzyme levels. Prx3 knockdown did not change D3’s affinity for T3 because saturation of D3-mediated whole-cell deiodination occurred between 20 and 200 nm T3 both with and without Prx3. Furthermore, the decrease in D3 activity in whole cells was not attributable to nonspecific oxidative stress because pretreatment with the antioxidant N-acetyl cysteine did not reverse the effects of Prx3 knockdown. Thioredoxin, the cofactor needed for Prx3 regeneration, supported D3 microsomal activity; however, Prx3 knockdown did not change D3 activity in this system. In conclusion, knockdown of Prx3 decreases D3 activity in whole cells, whereas absolute levels of D3 are unchanged, consistent with Prx3 playing a rate-limiting role in the regeneration of the D3 enzyme.


Sign in / Sign up

Export Citation Format

Share Document